Articles related to Pharmacy (Clinical/Hospital)

Healthcare leaders speaking at AXS26 argued that artificial intelligence tools affecting patient care require stronger oversight, including independent validation, bias monitoring, and human review. The discussion highlighted both operational opportunities and safety concerns surrounding healthcare AI adoption.

Attorneys speaking at a specialty pharmacy meeting warned that increased federal attention to fraud, waste, abuse, controlled substances, and reimbursement practices is driving greater scrutiny of pharmacies. The discussion focused on compliance preparedness rather than new regulatory requirements.

The FDA classified a recall of thyroid tablets USP 30 mg as Class I after identification of a superpotent product lot. The recall affects 1,955 bottles and carries risk of serious adverse health consequences, making prompt inventory review and product removal necessary.

A novel liposomal drug-delivery system prolonged tetrodotoxin nerve blockade to two to three weeks in rats, substantially exceeding currently available formulations. The findings highlight a potential strategy for sustained local anesthetic delivery, although clinical relevance remains unproven pending human validation.

The FDA approved updated 2026-2027 formulations of Pfizer-BioNTech, Moderna, and Novavax COVID-19 vaccines targeting the XFG variant, aligning with advisory committee recommendations for the upcoming vaccination season.

New consensus guidance favors once-daily oral iron and simplified IV administration, including fewer test doses, premedications, and infusion visits. Several recommendations depart from established protocols and require formulation-specific clinical judgment.